Drug stocks mixed as Idenix plunges
February 10, 2011 at 11:21 AM EST
Shares of Idenix tumble after the company released an update on its hepatitis C and HIV drug-development programs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.